The conversation around Ivermectin for cancer has dramatically shifted in 2025, moving from fringe speculation to the forefront of multiple clinical trials across the United States. While once controversial, this antiparasitic drug is now being tested for its anti-tumor properties, attracting attention from oncologists, integrative medicine practitioners, and patients...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek